In this presentation, Dr. Carrie Shawber of Columbia University explores the latest research into the genetics of fetal and pediatric lymphatic anomalies. Learn how new genetic discoveries are improving diagnosis, guiding personalized treatment strategies, and helping researchers identify promising new therapies—including preclinical studies of bortezomib. Dr. Shawber also discusses a groundbreaking ARPA-H initiative that is building one of the world's largest genetic databases for lymphatic anomalies to accelerate research and improve patient care.
Whether you're a patient, caregiver, clinician, or researcher, this presentation offers valuable insights into the future of precision medicine for lymphatic disorders.
Topics Covered:
- Genetics of lymphatic anomalies
- Fetal and pediatric lymphatic disorders
- Precision medicine and targeted therapies
- Emerging research on bortezomib
- Advances in genetic testing
- ARPA-H lymphatic genomics initiative
